{"id":426033,"date":"2024-12-16T00:00:00","date_gmt":"2024-12-16T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042083-medtech-peripheral-vascular-devices-market-insights-asia-pacific\/"},"modified":"2026-03-31T10:10:33","modified_gmt":"2026-03-31T10:10:33","slug":"47042083-medtech-peripheral-vascular-devices-market-insights-asia-pacific","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042083-medtech-peripheral-vascular-devices-market-insights-asia-pacific\/","title":{"rendered":"Peripheral Vascular Devices &#8211; Market Insights &#8211; Asia Pacific"},"content":{"rendered":"<p>The Asia Pacific <abbr title=\"Peripheral Vascular\">PV<\/abbr> device market will grow <span>modestly<\/span> over the forecast period, driven by the high prevalence of <abbr title=\"Peripheral Artery Disease\">PAD<\/abbr>, expanding <abbr title=\"Peripheral Artery Disease\">PAD<\/abbr>-related comorbidities, and rising adoption of premium-priced drug-eluting products. Rising procedure volumes for iliac and lower limb indications and the increasing adoption of endovascular techniques over surgical intervention will also fuel market growth, particularly in China. However, cost constraints in publicly funded healthcare systems and limited reimbursement in the region continue to hinder the adoption of premium-priced devices and limit the pace of revenue expansion.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the market for <abbr title=\"Peripheral Vascular\">PV<\/abbr> devices in the Asia Pacific region from 2019 through 2033.<\/p>\n<p class=\"question-statement\"><strong>Newer technologies will impact the current treatment trend in lower extremities.<\/strong><\/p>\n<p>What are the newer technologies that will change the treatment trend in lower extremities?<\/p>\n<p>How have these novel technologies impacted market share dynamics in the Asia Pacific region?<\/p>\n<p><strong>The expansion of <abbr data-abbreviation-entity=\"8829\" title=\"Drug-Eluting Stent(s)\">DES<\/abbr> and <abbr title=\"Drug-Coated Balloon\">DCB<\/abbr> markets will be driven by new device launches and positive clinical data.<\/strong><\/p>\n<p>What are some ongoing and completed clinical trials that will contribute to the launch of new <abbr data-abbreviation-entity=\"8829\" title=\"Drug-Eluting Stent(s)\">DES<\/abbr> and <abbr title=\"Drug-Coated Balloon\">DCB<\/abbr>s?<\/p>\n<p>Which competitors are likely to enter the <abbr title=\"Drug-Coated Balloon\">DCB<\/abbr> market, and which will gain the most market share?<\/p>\n<p>Will the emergence of <abbr title=\"Drug-Coated Balloon\">DCB<\/abbr>s have an impact on recently established <abbr title=\"Drug-Eluting Stent(s)\">DES<\/abbr> usage?<\/p>\n<p><b>M&#038;A activities or partnerships involving key competitors may lead to shifts in market shares going forward.<\/b><\/p>\n<p>Which acquisitions have occurred, and how will these acquisitions impact competitor performance in the future?<\/p>\n<p>How are competitors leveraging product portfolio acquisitions to expand their product offerings?<\/p>\n<p><strong>Budgetary constraints and insufficient reimbursement in some segments continue to affect the Asia Pacific <abbr title=\"Peripheral Vascular\">PV<\/abbr> device market.<\/strong><\/p>\n<p>To what extent the lack of reimbursement will affect the adoption of premium-priced devices such as <abbr data-abbreviation-entity=\"8829\" title=\"Drug-Eluting Stent(s)\">DES <\/abbr>and <abbr title=\"Drug-Coated Balloon\">DCB<\/abbr> and procedures such as atherectomy?<\/p>\n<p>How do the reimbursement landscapes differ in the Asia Pacific countries, and what are the recent regulations?<\/p>\n<p>What strategies are the competitors adopting to navigate the challenging cost-constrained Asia Pacific <abbr title=\"Peripheral Vascular\">PV<\/abbr> device market?<\/p>\n","protected":false},"template":"","class_list":["post-426033","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-therapy-area-peripheral-vascular-devices","medtech-geography-asia-pacific","medtech-date-983"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/426033","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":2,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/426033\/revisions"}],"predecessor-version":[{"id":575108,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/426033\/revisions\/575108"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=426033"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}